2Pi-Sigma is a biomedical company focused on developing a cheap, easy-to-use, and regular cancer screening test based on exosome-based liquid biopsies. The company, founded by Dr. Mehdi Hatamian, aims to create a $50 test that can be used monthly by individuals over 18 to detect a wide range of cancers, with an initial focus on lung, breast, colon, and prostate cancers. Their technology combines biology, biochemistry, electronics, and mechanical engineering to create a fully integrated platform, with the goal of enabling early detection and improving treatment outcomes.
